Study Stopped
Terminated due to no patient enrollment.
Lidocaine Supplement for Minimal Invasive Parathyroid Surgery
Prevention of Laryngeal Reflexes in Minimal Invasive Parathyroid Surgery by the Use of Topical Lidocaine
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Primary Objective: 1\. To determine if the application of lidocaine to the airway will obtund or abolish the laryngeal reflexes. This in turn will lead to a quiescent controlled surgical field.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2006
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2006
CompletedFirst Submitted
Initial submission to the registry
September 11, 2007
CompletedFirst Posted
Study publicly available on registry
September 12, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2008
CompletedDecember 7, 2012
December 1, 2012
1.6 years
September 11, 2007
December 5, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Severity of Airway Interruption
Assessment made by surgeon during minimally invasive parathyroidectomy surgery
Quality of Operative Field
Assessment made by surgeon during minimally invasive parathyroidectomy surgery
Study Arms (2)
Saline
EXPERIMENTALSaline misted into the air breathe during the surgery.
Lidocaine
EXPERIMENTALLidocaine misted into the air during the surgery.
Interventions
Eligibility Criteria
You may qualify if:
- All outpatients scheduled for MIPS at the ACB by Dr N Perrier, Dr D Evans and Dr JE Lee.
You may not qualify if:
- Patients who are excluded will be any who require elective endotracheal intubation as a preoperative decision by the anesthesia team. These patients will be those with sleep apnea, BMI\>35, uncontrolled gastro esophageal reflux.
- Patients who have a history of allergy/hypersensitivity to lidocaine.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Spencer Kee, MD
M.D. Anderson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2007
First Posted
September 12, 2007
Study Start
June 1, 2006
Primary Completion
January 1, 2008
Study Completion
January 1, 2008
Last Updated
December 7, 2012
Record last verified: 2012-12